An assessment of bone fluoride and osteosarcoma

Area of Science:

• Oncology
• Toxicology
• Biochemistry

Background:

• The link between fluoride exposure and osteosarcoma risk remains debated.
• Previous research has yielded conflicting results regarding fluoride's role in bone cancer development.

Purpose of the Study:

• To investigate whether individuals diagnosed with osteosarcoma exhibit elevated bone fluoride levels compared to controls.
• To clarify the controversial association between fluoride and osteosarcoma risk.

Main Methods:

• A case-control study involving 137 incident osteosarcoma cases and 51 tumor controls.
• Analysis of fluoride content in bone segments (tumor-adjacent and iliac crest).
• Logistic regression models were employed to assess the association, adjusting for relevant confounders.

Main Results:

• No statistically significant difference was observed in bone fluoride concentrations between osteosarcoma cases and control subjects.
• The adjusted odds ratio for osteosarcoma risk associated with bone fluoride levels was 1.33 (95% CI: 0.56-3.15).

Conclusions:

• This case-control study did not detect a significant association between bone fluoride levels and the risk of osteosarcoma.
• Findings suggest that elevated bone fluoride is unlikely to be a risk factor for osteosarcoma.